Sartorius AG
ISIN DE0007165631
|WKN 716563
Market cap (in EUR)
15,758.50 m
Country
Germany
Sector
Healthcare
Dividend yield
0.32%
Overview
Description
Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.
Healthcare Healthcare Services Miscellaneous Healthcare Germany
Financials
Key metrics
| Market capitalisation, EUR | 15,758.50 m |
| EPS, EUR | 1.38 |
| P/B ratio | 5.94 |
| P/E ratio | 168.51 |
| Dividend yield | 0.32% |
Income statement (2024)
| Revenue, EUR | 3,380.70 m |
| Net income, EUR | 84.00 m |
| Profit margin | 2.48% |
What ETF is Sartorius AG in?
There are 270 ETFs which contain Sartorius AG. All of these ETFs are listed in the table below. The ETF with the largest weighting of Sartorius AG is the Amundi TecDAX UCITS ETF Dist.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
